The role of microfluidics and 3D-bioprinting in the future of exosome therapy
Trends in Biotechnology · 2023
DOI: 10.1016/j.tibtech.2023.05.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2023. Verfasst von Mikele Amondarain und 5 weiteren Autor:innen. Beteiligte Einrichtung: CONICET - Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Laboratorio de Investigación Aplicada a Neurociencias …. Hauptthemen laut MEDLINE: Exosomes, Microfluidics, Printing, Three-Dimensional, Bioprinting. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
Exosome-based strategies constitute a promising tool for therapeutics, avoiding potential immunogenic and tumorigenic side-effects of cell therapies. However, the collection of a suitable exosome pool, and the need for high doses with conventional administration approaches, hamper their clinical translation. To overcome these challenges, versatile exosome collection strategies together with advanced delivery platforms may represent major progress in this field. Microfluidics enables large-scale gathering of both natural and synthetic exosomes for their implementation into bioinks, while 3D-bioprinting holds great promise in regenerative medicine with the use of exosome-loaded scaffolds that mimic the target tissue with controlled pharmacokinetics and pharmacodynamics. Hence, the combination of both strategies might become the key for the translation of exosome therapies to clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CONICET - Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Laboratorio de Investigación Aplicada a Neurociencias (LIAN), Buenos Aires, Argentina.
- Laboratory of Pharmaceutics, NanoBioCel Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicin…
Zitieren
APA
Amondarain, M., Gallego, I., Puras, G., Saenz-Del-Burgo, L., Luzzani, C., & Pedraz, J. L. (2023). The role of microfluidics and 3D-bioprinting in the future of exosome therapy. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2023.05.006
Vancouver
Amondarain M, Gallego I, Puras G, Saenz-Del-Burgo L, Luzzani C, Pedraz JL. The role of microfluidics and 3D-bioprinting in the future of exosome therapy. Trends in Biotechnology. 2023. doi:10.1016/j.tibtech.2023.05.006
BibTeX
@article{Amondarain2023,
author = {Amondarain, Mikele and Gallego, Idoia and Puras, Gustavo and Saenz-Del-Burgo, Laura and Luzzani, Carlos and Pedraz, José Luis},
title = {The role of microfluidics and 3D-bioprinting in the future of exosome therapy},
journal = {Trends in Biotechnology},
year = {2023},
doi = {10.1016/j.tibtech.2023.05.006}
}
EUVIMED